Overview
Background
Professor Rachel Thomson is a Head of the Greenslopes Clinical Unit, Thoracic Physician and clinical researcher working at Greenslopes Private Hospital.
She has an international reputation in the area of Pulmonary Nontuberculous mycobacterial disease. She has published widely in the area and is regularly invited to speak at international and national meetings.https://medical-school.uq.edu.au/research/ntm-research-group
Her current research focuses on immunological and environmental aspects of susceptibility to NTM infection, characteristics of the lung and gut microbiome in NTM, and improving treatment outcomes.
In a clinical capacity, Professor Thomson is able to offer patients expert management of their disease at Pulmedica, Greenslopes Private Hospital, at public clinics at The Prince Charles Hospital and the MetroSouth Clinical TB service of the Princess Alexandra Hospital and via telehealth for patients across Australia. Patients can also access novel treatments through clinical trials in both the private and public sector.
Prof Thomson also has a special interest in respiratory problems of the elite athlete. This includes asthma management, vocal cord dysfunction, and the requirements of national and international doping organisations for asthma medications.
Availability
- Professor Rachel Thomson is:
- Available for supervision
- Media expert
Fields of research
Research interests
-
Pulmonary nontuberculous mycobacterial disease
-
Genetic relatedness of mycobacterial strains
-
Environmental ecology of mycobacteria
Works
Search Professor Rachel Thomson’s works on UQ eSpace
2024
Journal Article
Pediatric physiotherapy management of airway clearance therapy and exercise: Data from the Australian Bronchiectasis Registry
Webb, Elizabeth M., Holland, Anne E., Chang, Anne B., Middleton, Peter G., Thomson, Rachel, Wong, Conroy, Jayaram, Lata, Holmes‐Liew, Chien‐Li, Morgan, Lucy and Lee, Annemarie L. (2024). Pediatric physiotherapy management of airway clearance therapy and exercise: Data from the Australian Bronchiectasis Registry. Pediatric Pulmonology. doi: 10.1002/ppul.27370
2024
Conference Publication
RCT Abstract - Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: Results of two randomized double-blind placebo-controlled phase 3 trials assessing safety and efficacy over 12 months
Haworth, Charles, Shteinberg, Michal, Winthrop, Kevin, Barker, Alan, Blasi, Francesco, Dimakou, Katerina, Morgan, Lucy, O'Donnell, Anne, Ringhausen, Felix, Sibila, Oriol, Thomson, Rachel, Carroll, Kevin, Pontenani, Federica, Castellani, Paola and Chalmers, James (2024). RCT Abstract - Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: Results of two randomized double-blind placebo-controlled phase 3 trials assessing safety and efficacy over 12 months. European Respiratory Society. doi: 10.1183/13993003.congress-2024.rct5390
2024
Journal Article
Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months
Haworth, Charles S, Shteinberg, Michal, Winthrop, Kevin, Barker, Alan, Blasi, Francesco, Dimakou, Katerina, Morgan, Lucy C, O'Donnell, Anne E, Ringshausen, Felix C, Sibila, Oriol, Thomson, Rachel M, Carroll, Kevin J, Pontenani, Federica, Castellani, Paola and Chalmers, James D (2024). Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months. The Lancet Respiratory Medicine, 12 (10), 787-798. doi: 10.1016/s2213-2600(24)00225-x
2024
Journal Article
Current physiotherapy practice for adults with bronchiectasis: data from the Australian Bronchiectasis Registry
Webb, Elizabeth M., Holland, Anne E., Chang, Anne B., Burr, Lucy, Holmes-Liew, Chien-Li, King, Paul T., Middleton, Peter G., Morgan, Lucy, Thomson, Rachel M., Wong, Conroy and Lee, Annemarie L. (2024). Current physiotherapy practice for adults with bronchiectasis: data from the Australian Bronchiectasis Registry. Respiratory Medicine, 233 107777, 107777. doi: 10.1016/j.rmed.2024.107777
2024
Conference Publication
Developing a pharmacovigilance framework for an investigator-led, non-commercial platform trial – finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT)
Hicks, D., Jong, T., Rice, M., Gailer, N., Joshi, S., Stevens, L., Lee, K., Thomson, R., Burke, A., Grimwood, K., Bell, S., Clark, J. and Wainwright, C.E. (2024). Developing a pharmacovigilance framework for an investigator-led, non-commercial platform trial – finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT). 47th European Cystic Fibrosis Conference, Glasgow, United Kingdom, 5-8 June 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s1569-1993(24)00244-3
2024
Conference Publication
Validation of the BACES Severity Scoring System in an Australian Cohort of Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) Patients
Mishiro, K., Ballard, E., Goh, F. and Thomson, R. (2024). Validation of the BACES Severity Scoring System in an Australian Cohort of Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) Patients . American Thoracic Society International Conference 2024, San Diego, CA United States, 17-22 May 2024. New York, NY United States: American Thoracic Society. doi: 10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a3158
2024
Journal Article
OPTIMA: an open-label, non-comparative pilot trial of inhaled molgramostim in pulmonary nontuberculous mycobacterial infection
Thomson, Rachel M., Loebinger, Michael R., Burke, Andrew J., Morgan, Lucy C., Waterer, Grant W. and Ganslandt, Cecilia (2024). OPTIMA: an open-label, non-comparative pilot trial of inhaled molgramostim in pulmonary nontuberculous mycobacterial infection. Annals of the American Thoracic Society, 21 (4), 568-576. doi: 10.1513/annalsats.202306-532oc
2023
Journal Article
Extended water stagnation in buildings during the COVID-19 pandemic increases the risks posed by opportunistic pathogens
Huang, Casey K., Weerasekara, Anjani, Lu, Ji, Carter, Robyn, Weynberg, Karen D., Thomson, Rachel, Bell, Scott and Guo, Jianhua (2023). Extended water stagnation in buildings during the COVID-19 pandemic increases the risks posed by opportunistic pathogens. Water Research: X, 21 100201, 100201. doi: 10.1016/j.wroa.2023.100201
2023
Journal Article
Things They Are a Changing in the Field of Nontuberculous Mycobacteria
Kasperbauer, Shannon and Thomson, Rachel (2023). Things They Are a Changing in the Field of Nontuberculous Mycobacteria. Clinics in Chest Medicine, 44 (4), xiii-xiv. doi: 10.1016/j.ccm.2023.09.001
2023
Journal Article
In vitro susceptibility testing of imipenem- relebactam and tedizolid against 102 Mycobacterium abscessus isolates
Burke, Andrew, Carter, Robyn, Tolson, Carla, Congdon, Jacob, Duplancic, Christine, Bursle, Evan, Bell, Scott C., Roberts, Jason A. and Thomson, Rachel (2023). In vitro susceptibility testing of imipenem- relebactam and tedizolid against 102 Mycobacterium abscessus isolates. International Journal of Antimicrobial Agents, 62 (4) 106938, 1-6. doi: 10.1016/j.ijantimicag.2023.106938
2023
Journal Article
A systematic review of the clinical impact of small colony variants in patients with cystic fibrosis
Ryan, Harrigan, Ballard, Emma, Stockwell, Rebecca E., Duplancic, Christine, Thomson, Rachel M., Smith, Kimberley and Bell, Scott C. (2023). A systematic review of the clinical impact of small colony variants in patients with cystic fibrosis. BMC Pulmonary Medicine, 23 (1) 323, 1-10. doi: 10.1186/s12890-023-02611-4
2023
Conference Publication
In vitro susceptibility testing of imipenem- relebactam and tedizolid against australian mycobacterium abscessus isolates
Burke, A. J., Carter, R., Tolson, C., Congdon, J., Duplancic, C., Bursle, E., Bell, S., Roberts, J. and Thomson, R. (2023). In vitro susceptibility testing of imipenem- relebactam and tedizolid against australian mycobacterium abscessus isolates. ATS 2023 International Conference, Washington, DC USA, 19-24 May 2023. Washington, DC USA: American Thoracic Society. doi: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2968
2023
Conference Publication
Evolution of antimicrobial resistance in Mycobacterium abscessus isolated from drinking water
Patterson-Fahy, K., Carter, R., Guo, J. and Thomson, R. (2023). Evolution of antimicrobial resistance in Mycobacterium abscessus isolated from drinking water. International Conference of the American Thoracic Society (ATS) 2023, Washington, DC, United States, 19 - 24 May 2023. New York, NY, United States: American Thoracic Society. doi: 10.1164/ajrccm-conference.2023.207.1_MeetingAbstracts.A2952
2023
Conference Publication
A method for the isolation of environmental Mycobacterium species from soil and house dust
Carter, R. M., Huygens, F. and Thomson, R. (2023). A method for the isolation of environmental Mycobacterium species from soil and house dust. International Conference of the American Thoracic Society (ATS) 2023, Washington, DC, United States, 19 - 24 May 2023. New York, NY, United States: American Thoracic Society. doi: 10.1164/ajrccm-conference.2023.207.1_MeetingAbstracts.A3594
2023
Conference Publication
Mycobacterium abscessus: Acquisition and transmission pathways
Ramsay, K., Smith, K., Carter, R., Clayton, M., Burke, A., Wainwright, C., Thomson, R. and Bell, S. (2023). Mycobacterium abscessus: Acquisition and transmission pathways. TSANZSRS 2023 The Australia and New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health and Respiratory Science, Christchurch, New Zealand, 25–28 March 2023. Richmond, VIC Australia: John Wiley and Sons. doi: 10.1111/resp.14459
2023
Journal Article
Environmental risk of nontuberculous mycobacterial infection: strategies for advancing methodology
Mercaldo, Rachel A., Marshall, Julia E., Cangelosi, Gerard A., Donohue, Maura, Falkinham, Joseph O., Fierer, Noah, French, Joshua P., Gebert, Matthew J., Honda, Jennifer R., Lipner, Ettie M., Marras, Theodore K., Morimoto, Kozo, Salfinger, Max, Stout, Janet, Thomson, Rachel and Prevots, D. Rebecca (2023). Environmental risk of nontuberculous mycobacterial infection: strategies for advancing methodology. Tuberculosis, 139 102305, 102305. doi: 10.1016/j.tube.2023.102305
2023
Conference Publication
Nontuberculous mycobacteria in Australians with cystic fibrosis: A national survey
Bell, S., Duplancic, C., Wainwright, C., Thomson, R., Rogers, G., Clements, A. and Floto, R. (2023). Nontuberculous mycobacteria in Australians with cystic fibrosis: A national survey. TSANZSRS 2023 Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science, Christchurch, New Zealand, 25 - 28 March 2023. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/resp.14459
2023
Conference Publication
Distribution and diversity of respiratory and non-respiratory Mycobacterium abscessus infections
Smith, K., Taylor, S., Zheng, L., Rogers, G., Coulter, C., Pandey, S., Thomson, R. and Bell, S. (2023). Distribution and diversity of respiratory and non-respiratory Mycobacterium abscessus infections. TSANZSRS 2023 The Australia and New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health and Respiratory Science, Christchurch, New Zealand, 25–28 March 2023. Richmond, VIC Australia: John Wiley and Sons. doi: 10.1111/resp.14459
2023
Conference Publication
Validation of cromolyn sodium as a marker of aspiration
Riddles, T., Semple, K. and Thomson, R. (2023). Validation of cromolyn sodium as a marker of aspiration. TSANZSRS 2023 (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science, Christchurch, New Zealand, 25 - 28 March 2023. Richmond, VIC, Australia: John Wiley & Sons.
2023
Journal Article
Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator Modulators
Burke, Andrew, Thomson, Rachel M., Wainwright, Claire E. and Bell, Scott C. (2023). Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator Modulators. Seminars in Respiratory and Critical Care Medicine, 44 (02), 287-296. doi: 10.1055/s-0042-1759883
Funding
Current funding
Past funding
Supervision
Availability
- Professor Rachel Thomson is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Transmission dynamics of multi-drug resistant tuberculosis amongst immune suppressed patients exposed to an infectious case
Principal Advisor
Other advisors: Professor Antje Blumenthal
-
Doctor Philosophy
The nature of the relationship between patient and environmental isolates of Mycobacterium intracellulare in Queensland.
Principal Advisor
-
Master Philosophy
The gut-lung axis in nontuberculous mycobacterial pulmonary disease.
Principal Advisor
Other advisors: Professor Mark Morrison, Professor Antje Blumenthal
-
Doctor Philosophy
Risk and mitigation of cough aerosols for people with cystic fibrosis.
Associate Advisor
Other advisors: Professor Scott Bell
-
Doctor Philosophy
Risk and mitigation of cough aerosols for people with cystic fibrosis.
Associate Advisor
Other advisors: Professor Scott Bell
-
Doctor Philosophy
Pharmacokinetics of anti-mycobacterial drugs in patients with cystic fibrosis
Associate Advisor
Other advisors: Professor Scott Bell, Professor Jason Roberts
Completed supervision
-
2017
Master Philosophy
Environmental transmission factors and host genetic polymorphisms influencing NTM infection in patients with no overt immunodeficiency
Principal Advisor
Media
Enquiries
Contact Professor Rachel Thomson directly for media enquiries about:
- Mycobacterial diseases
- mycobacterial infections
- Pulmonary Nontuberculous mycobacterial infections
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: